Background Readmission rates following hospitalisation for COPD exacerbations are
unacceptably high, and the contributing factors are poorly understood. Our objective was to …

Patients with chronic obstructive pulmonary disease (COPD) may suffer from acute episodes
of worsening dyspnea, often associated with increased cough, sputum, and/or sputum …

Background The effect of procalcitonin-guided use of antibiotics on treatment for suspected
lower respiratory tract infection is unclear. Methods In 14 US hospitals with high adherence …

Background Early hospital readmissions remain common in patients with conditions
targeted by the CMS Hospital Readmission Reduction Program (HRRP). There is still no …

Background Chronic obstructive pulmonary disease (COPD) is associated with multiple
comorbidities, which impact negatively on patients and are often underdiagnosed, thus …

Rationale: Implementation of the Hospital Readmissions Reduction Program (HRRP)
following discharge of patients with chronic obstructive pulmonary disease (COPD) has led …

Introduction Chronic obstructive pulmonary disease (COPD) is the third-leading cause of
death globally and is responsible for over 3 million deaths annually. One of the factors …

Randomized controlled trials (RCTs) are preferred by payers for health technology
assessments and coverage decisions. However, the inclusion of a highly selective patient …

Background Despite hospitalization for exacerbation being a high-risk event for morbidity
and mortality, there is little consensus globally regarding the assessment and management …

Background Patients with chronic obstructive pulmonary disease (COPD) are more likely to
be readmitted than patients with other chronic medical conditions, yet knowledge regarding …